HK129693A - Porphyrins and medicaments for cancer treatment - Google Patents

Porphyrins and medicaments for cancer treatment

Info

Publication number
HK129693A
HK129693A HK1296/93A HK129693A HK129693A HK 129693 A HK129693 A HK 129693A HK 1296/93 A HK1296/93 A HK 1296/93A HK 129693 A HK129693 A HK 129693A HK 129693 A HK129693 A HK 129693A
Authority
HK
Hong Kong
Prior art keywords
porphyrins
medicaments
cancer treatment
same
compound
Prior art date
Application number
HK1296/93A
Other languages
English (en)
Inventor
Raymond Bonnett
Morris Cyril Berenbaum
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of HK129693A publication Critical patent/HK129693A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK1296/93A 1988-03-11 1993-11-25 Porphyrins and medicaments for cancer treatment HK129693A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888805849A GB8805849D0 (en) 1988-03-11 1988-03-11 Porphyrins & cancer treatment

Publications (1)

Publication Number Publication Date
HK129693A true HK129693A (en) 1993-12-03

Family

ID=10633278

Family Applications (1)

Application Number Title Priority Date Filing Date
HK1296/93A HK129693A (en) 1988-03-11 1993-11-25 Porphyrins and medicaments for cancer treatment

Country Status (17)

Country Link
US (1) US4992257A (nl)
EP (1) EP0337601B1 (nl)
JP (1) JP2785033B2 (nl)
KR (1) KR970011392B1 (nl)
AT (1) ATE89002T1 (nl)
AU (1) AU611774C (nl)
BR (1) BR1100662A (nl)
CA (1) CA1338737C (nl)
DE (2) DE10299012I2 (nl)
ES (1) ES2055038T3 (nl)
GB (1) GB8805849D0 (nl)
HK (1) HK129693A (nl)
IE (1) IE63290B1 (nl)
LU (1) LU90907I2 (nl)
NL (1) NL300089I2 (nl)
NZ (1) NZ228225A (nl)
ZA (1) ZA891653B (nl)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162519A (en) * 1988-03-11 1992-11-10 Efamol Holdings Plc Porphyrins and cancer treatment
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
US5262532A (en) * 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
US6362175B1 (en) 1991-09-20 2002-03-26 The Trustees Of The University Of Pennsylvania Porphyrin compounds for imaging tissue oxygen
PT947222E (pt) * 1992-11-20 2006-09-29 Univ British Columbia Metodo de activacao de agentes fotossensiveis
US6127356A (en) * 1993-10-15 2000-10-03 Duke University Oxidant scavengers
JPH07233065A (ja) 1993-12-27 1995-09-05 Canon Inc ピリリウム塩又はピリリウム類似塩を含む光化学治療薬
GB9408746D0 (en) * 1994-05-03 1994-06-22 Scotia Holdings Plc Tumour locallising photosensitising compounds
AU3758695A (en) * 1994-09-20 1996-04-09 Duke University Oxidoreductase activity of manganic porphyrins
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
AU725602B2 (en) * 1995-06-07 2000-10-12 Duke University Oxidant scavengers
US5877165A (en) * 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
ATE230801T1 (de) 1996-10-03 2003-01-15 Canon Kk Verfahren zur detektion von zielnukleinsäure, verfahren zu ihrer quantifizierung und pyrylium- verbindungen zur chemilumineszenz-analyse
US6582392B1 (en) * 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
EP1045851B1 (en) 1997-11-03 2003-04-23 Duke University Substituted porphyrins
DE19814405C2 (de) * 1998-03-31 2000-03-02 Schastak Astrid Porphyrine und ihre Verwendung als Photosensitizer
AU771259B2 (en) 1998-04-24 2004-03-18 Aeolus Sciences, Inc. Substituted porphyrins
EP1107971B1 (en) * 1998-08-28 2004-11-24 Destiny Pharma Limited Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
ES2385486T3 (es) 1999-01-25 2012-07-25 National Jewish Health Porfirinas sustituidas y su uso terapéutico
US6482943B1 (en) * 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
GB0001455D0 (en) * 2000-01-21 2000-03-15 Scotia Holdings Plc Porphyrins and related compounds
DK1392328T3 (da) 2001-01-19 2009-11-09 Nat Jewish Health Medikament til beskyttelse i radioterapi
CA2449024A1 (en) 2001-06-01 2002-12-12 National Jewish Medical And Research Center Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
ATE520362T1 (de) 2001-12-03 2011-09-15 Ekos Corp Katheter mit mehreren ultraschall-abstrahlenden teilen
PT102721B (pt) * 2002-02-01 2011-01-24 Cipan Companhia Industr Prod De Antibioticos S A Compostos macrocíclicos tetrapirrólicos com rendimento quântico de oxigénio singuleto adequado à terapia fotodinâmica e processos para a sua preparação
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
WO2003103680A1 (en) 2002-06-07 2003-12-18 Duke University Substituted porphyrins
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
ITFI20020200A1 (it) * 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
CA2437638A1 (en) 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
BRPI0511897A (pt) 2004-06-09 2008-01-15 Quadra Logic Tech Inc método para tratar distúrbios de glándula sebácea hiperativa, e, uso de uma composição fotossensibilizadora hidrofóbica e/ou lipofìlica
US7825153B2 (en) * 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
DE102005015286A1 (de) * 2005-04-04 2006-10-05 Tetrapdt Gmbh Photosensibilisatoren als Arzneimittelträger für lokale Markierung und Therapie von neoplastischem Gewebe
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
ES2471118T3 (es) 2007-06-22 2014-06-25 Ekos Corporation Método y aparato para el tratamiento de hemorragias intracraneales
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
WO2009079415A1 (en) * 2007-12-14 2009-06-25 Ekos Corporation Ultrasound pulse shaping
EP2732817B1 (en) 2008-05-23 2016-08-24 National Jewish Health A compound for use in treating injury associated with exposure to phosgene or chlorine gas
CN102159569B (zh) 2008-09-18 2016-02-03 拜莱泰克制药市场有限公司 用于pdt的不对称内消旋取代的卟啉和二氢卟酚及其应用
US9211283B2 (en) 2009-12-11 2015-12-15 Biolitec Pharma Marketing Ltd Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
CN103607999A (zh) 2011-01-13 2014-02-26 Qlt股份有限公司 局部递送光敏剂的药物组合物及其用途
MX2015000429A (es) 2012-07-11 2015-07-14 Dermira Inc Composiciones farmaceuticas para el suministro topico de fotosesibilizadores y usos de los mismos.
US9550072B2 (en) 2012-08-03 2017-01-24 Cerca Solutions, LLC Diagnostic device, therapeutic device, and uses thereof
EP3201201B1 (en) 2014-09-30 2022-01-26 biolitec unternehmensbeteiligungs II AG Specifically meso-substituted porphyrins and chlorins for photodynamic therapy
US10656025B2 (en) 2015-06-10 2020-05-19 Ekos Corporation Ultrasound catheter
EP3894421A1 (en) 2018-12-10 2021-10-20 Universität Hamburg Specifically glyco-substituted porphyrins and chlorins for photodynamic therapy
EP4225759A1 (en) 2020-10-05 2023-08-16 biolitec Unternehmensbeteiligungs II AG Tetrapyrrole-based compounds and their formulations for anti-microbial therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2740794A (en) * 1954-07-26 1956-04-03 Exxon Research Engineering Co Synthesis of novel vanadium porphyrin
US3076813A (en) * 1957-11-13 1963-02-05 Monsanto Chemicals alpha, beta, gamma, sigma-tetra-arylporphins
US3687863A (en) * 1970-05-25 1972-08-29 Gen Telephone & Elect Optical filters containing tetraphenyl-porphins and method of making same
DE2308252A1 (de) * 1973-02-20 1974-08-22 Basf Ag Verfahren zur herstellung von mesotetraarylporphinen
US4330637A (en) * 1981-01-05 1982-05-18 Western Electric Company, Inc. Encapsulated electronic devices and encapsulating compositions
EP0127797B1 (de) * 1983-06-03 1987-06-16 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Markermoleküle für Fluoreszenz-Immuno-Assays sowie Verfahren und Zwischenprodukte zu deren Herstellung
GB8429845D0 (en) * 1984-11-26 1985-01-03 Efamol Ltd Porphyrins & cancer treatment
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments

Also Published As

Publication number Publication date
ES2055038T3 (es) 1994-08-16
KR890014548A (ko) 1989-10-24
US4992257A (en) 1991-02-12
IE63290B1 (en) 1995-04-05
DE10299012I1 (de) 2002-07-18
AU611774C (en) 2002-02-21
JPH01275528A (ja) 1989-11-06
ZA891653B (en) 1989-11-29
DE10299012I2 (de) 2004-05-06
AU611774B2 (en) 1991-06-20
LU90907I2 (fr) 2003-04-30
DE68906301T2 (de) 1993-09-30
GB8805849D0 (en) 1988-04-13
NL300089I1 (nl) 2002-07-01
EP0337601A1 (en) 1989-10-18
JP2785033B2 (ja) 1998-08-13
EP0337601B1 (en) 1993-05-05
BR1100662A (pt) 1999-10-13
KR970011392B1 (ko) 1997-07-10
NZ228225A (en) 1990-08-28
IE890687L (en) 1989-09-11
CA1338737C (en) 1996-11-26
AU3097589A (en) 1989-09-14
DE68906301D1 (de) 1993-06-09
NL300089I2 (nl) 2002-08-01
ATE89002T1 (de) 1993-05-15

Similar Documents

Publication Publication Date Title
HK129693A (en) Porphyrins and medicaments for cancer treatment
AU578329B2 (en) Anti cancer treatment with porphyrins
IN170909B (nl)
AU7404791A (en) Treatment of cataract with 15-keto-prostaglandin compounds
NZ227131A (en) Compositions for improving cognitive function by administering 1,2-oxazole derivatives
CA2030346A1 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
AU584270B2 (en) Novel derivatives of erythromycylamine
ATE153340T1 (de) Cyathane derivate und diese enthaltende nervenwachstumsfaktor produktion stimulatoren und antimikrobielle mittel
EP0551844A3 (nl)
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
AU6029090A (en) Improvements in or relating to organic compounds

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090226